David Chaplin — 18 Patents at Oxigene

David Chaplin has been granted 18 US patents while listed as an inventor at Oxigene. The first was granted in 1990 and the most recent in August 2022. David Chaplin ranks #245,716 of 4,157,543 US inventors in our database (top 5.9%). Patent records list David Chaplin in Watlington, BC, GB.

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11419934	Use of VDAS to enhance immunomodulating therapies against tumors	Kimberly Perkins	2022-08-23
9873668	Compositions and methods for inhibition of cathepsins	Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary Lynn Trawick	2018-01-23
9458103	Compositions and methods for inhibition of cathepsins	Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary Lynn Trawick	2016-10-04
RE45907	Functionalized stilbene derivatives as improved vascular targeting agents	Charles Garner, Robert R. Kane, Kevin G. Pinney, Joseph Prezioso, Klaus Edvardsen	2016-03-01
RE45720	Functionalized stilbene derivatives as improved vascular targeting agents	Charles Garner, Robert R. Kane, Kevin G. Pinney, Joseph Prezioso, Klaus Edvardsen	2015-10-06
9040500	Method for treating hematopoietic neoplasms	Bronwyn G. Siim	2015-05-26	$459,000
8877967	Compositions and methods for inhibition of cathepsins	Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary Lynn Trawick	2014-11-04	$1,263,000
8198302	Compositions and methods with enhanced therapeutic activity	Klaus Edvardsen, Kevin G. Pinney, Joseph Prezioso, Mark Wood	2012-06-12	$296,000
7456214	Chromene-containing compounds with anti-tubulin and vascular targeting activity	Kevin G. Pinney, Phyllis Arthasary, Anupama Shirali, Klaus Edvardsen	2008-11-25	$474,000
7384925	Functionalized stilbene derivatives as improved vascular targeting agents	Charles Garner, Robert R. Kane, Kevin G. Pinney, Joseph Prezioso, Klaus Edvardsen	2008-06-10	$429,000
7358236	Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents	Scott Young	2008-04-15	$587,000
7091240	Tubulin binding ligands and corresponding prodrug constructs	Kevin G. Pinney, Vani P. Mocharla, Zhi Chen, Charles Garner, Mallinath Hadimani +5 more	2006-08-15	$984,000
7001926	Tubulin binding agents and corresponding prodrug constructs	Kevin G. Pinney, Vani P. Mocharla, Zhi Chen, Mallinath Hadimani, Jimmy Kessler +4 more	2006-02-21	$1,144,000
6919324	Functionalized stilbene derivatives as improved vascular targeting agents	Charles Garner, Robert R. Kane, Kevin G. Pinney, Joseph Prezioso, Klaus Edvardsen	2005-07-19	$1,211,000
6713517	Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use	Ronald W. Pero, Anders Olsson, Tomas Ekberg, Alan Schwartz	2004-03-30	$5,773,000
6028111	Compositions and use of benzamides and nicotinamides as anti-inflammatory agents	Ronald W. Pero	2000-02-22	$4,216,000
5026694	Platinum complexes with one radiosensitizing ligand	Kirsten A. Skov, Nicholas Farrell	1991-06-25
4921963	Platinum complexes with one radiosensitizing ligand	Kirsten A. Skov, Nicholas Farrell	1990-05-01

David Chaplin — 18 Patents

Issued Patents All Time

Patent Widget